These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The peripheral vascular effects of nifedipine in Raynaud's syndrome associated with scleroderma: a double blind crossover study. Finch MB, Dawson J, Johnston GD. Clin Rheumatol; 1986 Dec; 5(4):493-8. PubMed ID: 3816096 [Abstract] [Full Text] [Related]
3. Slow release nifedipine in the treatment of Raynaud's phenomenon. Costantini A, Martelli E, Bavera P, Agus GB. Int Angiol; 1987 Dec; 6(4):359-63. PubMed ID: 3330116 [Abstract] [Full Text] [Related]
4. [Calcium antagonists for the treatment of Raynaud's phenomenon]. Müller-Bühl U, Diehm C, Scheuermann W, Mörl H. Dtsch Med Wochenschr; 1983 Nov 25; 108(47):1795-7. PubMed ID: 6357692 [Abstract] [Full Text] [Related]
5. Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects. Kallenberg CG, Wouda AA, Kuitert JJ, Tijssen J, Wesseling H. J Rheumatol; 1987 Apr 25; 14(2):284-90. PubMed ID: 3598997 [Abstract] [Full Text] [Related]
6. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker. Rupp PA, Mellinger S, Kohler J, Dorsey JK, Furst DE. J Rheumatol; 1987 Aug 25; 14(4):745-50. PubMed ID: 3312603 [Abstract] [Full Text] [Related]
7. [Treatment of Raynaud's syndrome with calcium entry blockers]. Shcherbakov AB, Guseva NG, Mach ES. Ter Arkh; 1987 Aug 25; 59(4):89-92. PubMed ID: 3296288 [Abstract] [Full Text] [Related]
8. [Controlled study of nifedipine in the treatment of Raynaud's phenomenon]. Kahan A, Weber S, Amor B, Saporta L, Hodara M, Degeorges M. Rev Rhum Mal Osteoartic; 1982 Apr 25; 49(5):337-43. PubMed ID: 6285445 [Abstract] [Full Text] [Related]
9. Nifedipine and Raynaud's phenomenon associated with connective tissue diseases. Kahan A, Weber S, Amor B, Menkes CJ, Hodara M, Degeorges M. Int Angiol; 1985 Apr 25; 4(2):221-3. PubMed ID: 3831143 [Abstract] [Full Text] [Related]
10. Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon. Gjørup T, Kelbaek H, Hartling OJ, Nielsen SL. Am Heart J; 1986 Apr 25; 111(4):742-5. PubMed ID: 3513504 [Abstract] [Full Text] [Related]
11. [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon]. Vayssairat M, Blaison N, Baudot N, Evenou P, Gilard M, Mathieu JF. J Mal Vasc; 1989 Apr 25; 14(4):299-302. PubMed ID: 2584886 [Abstract] [Full Text] [Related]
12. A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon. Corbin DO, Wood DA, Macintyre CC, Housley E. Eur Heart J; 1986 Feb 25; 7(2):165-70. PubMed ID: 3516704 [Abstract] [Full Text] [Related]
13. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study. Rademaker M, Cooke ED, Almond NE, Beacham JA, Smith RE, Mant TG, Kirby JD. BMJ; 1989 Mar 04; 298(6673):561-4. PubMed ID: 2467711 [Abstract] [Full Text] [Related]
14. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial. Sauza J, Kraus A, González-Amaro R, Alarcón-Segovia D. J Rheumatol; 1984 Jun 04; 11(3):362-4. PubMed ID: 6376801 [Abstract] [Full Text] [Related]
17. [Nicardipine in the treatment of Raynaud's phenomenon]. Kahan A, Amor B, Menkès CJ. Rev Rhum Mal Osteoartic; 1987 Jun 04; 54(6):487-90. PubMed ID: 3303287 [Abstract] [Full Text] [Related]
18. Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud's phenomenon. Challenor VF, Waller DG, Hayward RA, Griffin MJ, Roath OS. Angiology; 1989 Feb 04; 40(2):122-8. PubMed ID: 2644877 [Abstract] [Full Text] [Related]